A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells

Journal of Immunology

Volumn 185, Issue 12, 2010, Pages 7537-7543

  Berland, Robert ^a,d   Fiering, Steven ^b,c   Wortis, Henry H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Microbiology and Immunology ^*  (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAKPOINT CLUSTER REGION PROTEIN; CD5 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; ENHANCER REGION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOSS; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

AGING; ANIMALS; ANTIGENS, CD5; B-LYMPHOCYTES; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; IMMUNOLOGIC CAPPING; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; ORGAN SPECIFICITY; PERITONEAL CAVITY; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; T-LYMPHOCYTES;

EID: 78650674703     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002173     Document Type: Article

References (70)

1. Aruffo, A., M. B. Melnick, P. S. Linsley, and B. Seed. 1991. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exp. Med. 174:949-952.
2. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:2301-2311.
3. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253-300.
4. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28:639-650.
5. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105:4390-4398.
6. Lee, J., S. Kuchen, R. Fischer, S. Chang, and P. E. Lipsky. 2009. Identification and characterization of a human CD5+ pre-naive B cell population. J. Immunol. 182:4116-4126.
7. Zhou, W., H. Ohdan, Y. Tanaka, H. Hara, D. Tokita, T. Onoe, and T. Asahara. 2003. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Transpl. Immunol. 12:9-18.
8. Chiorazzi, N., and M. Ferrarini. 2003. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21:841-894.
9. Osman, N., S. C. Ley, and M. J. Crumpton. 1992. Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur. J. Immunol. 22:2995-3000.
10. Burgess, K. E., M. Yamamoto, K. V. Prasad, and C. E. Rudd. 1992. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc. Natl. Acad. Sci. USA 89:9311-9315.
11. Lankester, A. C., G. M. van Schijndel, J. L. Cordell, C. J. van Noesel, and R. A. van Lier. 1994. CD5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24:812-816.
12. Tarakhovsky, A., S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Müller, N. Killeen, and K. Rajewsky. 1995. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269:535-537.
13. Bikah, G., J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274:1906-1909.
14. Azzam, H. S., J. B. DeJarnette, K. Huang, R. Emmons, C. S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love. 2001. Fine tuning of TCR signaling by CD5. J. Immunol. 166:5464-5472.
15. Brossard, C., M. Semichon, A. Trautmann, and G. Bismuth. 2003. CD5 inhibits signaling at the immunological synapse without impairing its formation. J. Immunol. 170:4623-4629.
16. Hawiger, D., R. F. Masilamani, E. Bettelli, V. K. Kuchroo, and M. C. Nussenzweig. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20:695-705.
17. Hippen, K. L., L. E. Tze, and T. W. Behrens. 2000. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191:883-890.
18. Geppert, T. D., and P. E. Lipsky. 1988. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3: regulatory influences of monoclonal antibodies to additional T cell surface determinants. J. Clin. Invest. 81:1497-1505.
19. Gringhuis, S. I., L. F. de Leij, P. J. Coffer, and E. Vellenga. 1998. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes. Mol. Cell. Biol. 18:1725-1735.
20. Axtell, R. C., M. S. Webb, S. R. Barnum, and C. Raman. 2004. Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J. Immunol. 173:2928-2932.
21. Gary-Gouy, H., J. Harriague, G. Bismuth, C. Platzer, C. Schmitt, and A. H. Dalloul. 2002. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood 100:4537-4543.
22. Perez-Chacon, G., J. A. Vargas, J. Jorda, M. Morado, S. Rosado, T. Martin-Donaire, I. Losada-Fernandez, N. Rebolleda, and P. Perez-Aciego. 2007. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC. Leuk. Res. 31:183-193.
23. Berland, R., L. Fernandez, E. Kari, J. H. Han, I. Lomakin, S. Akira, H. H. Wortis, J. F. Kearney, A. A. Ucci, and T. Imanishi-Kari. 2006. Toll-like receptor 7-de-pendent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25:429-440.
24. - B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 3:467-476.
25. Wortis, H. H., M. Teutsch, M. Higer, J. Zheng, and D. C. Parker. 1995. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl. Acad. Sci. USA 92:3348-3352.
26. Smith, K., B. Seddon, M. A. Purbhoo, R. Zamoyska, A. G. Fisher, and M. Merkenschlager. 2001. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194:1253-1261.
27. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617-629.
28. Klinman, D. M., and K. L. Holmes. 1990. Differences in the repertoire expressed by peritoneal and splenic Ly-1 (CD5) + B cells. J. Immunol. 144:4520-4525.
29. Tumang, J. R., R. Francés, S. G. Yeo, and T. L. Rothstein. 2005. Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J. Immunol. 174:3173-3177.
30. Briles, D. E., M. Nahm, K. Schroer, J. Davie, P. Baker, J. Kearney, and R. Barletta. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumo-niae. J. Exp. Med. 153:694-705.
31. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188:2381-2386.
32. Reid, R. R., S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen, Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2002. Functional activity of natural antibody is altered in Cr2-deficient mice. J. Immunol. 169:5433-5440.
33. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271-280.
34. Shaw, P. X., S. Hörkkö, M. K. Chang, L. K. Curtiss, W. Palinski, G. J. Silverman, and J. L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:1731-1740.
35. Macpherson, A. J., D. Gatto, E. Sainsbury, G. R. Harriman, H. Hengartner, and R. M. Zinkernagel. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria Science 288:2222-2226.
36. Hayakawa, K., M. Asano, S. A. Shinton, M. Gui, D. Allman, C. L. Stewart, J. Silver, and R. R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science 285:113-116.
37. Berland, R., and H. H. Wortis. 1998. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J. Immunol. 161:277-285.
38. Huang, H. J. 1987. Molecular cloning and characterization of the murine lymphocyte differentiation antigen Ly-1 (murine CD5). Doctoral dissertation, Stanford University, Palo Alto, CA.
39. Dinkel, A., W. K. Aicher, K. Warnatz, K. Bürki, H. Eibel, and B. Ledermann. 1999. Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells. J. Immunol. Methods 223:255-260.
40. Tarakhovsky, A., W. Müller, and K. Rajewsky. 1994. Lymphocyte populations and immune responses in CD5-deficient mice. Eur. J. Immunol. 24:1678-1684.
41. Rothenberg, E. V., J. E. Moore, and M. A. Yui. 2008. Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8:9-21.
42. Godfrey, D. I., A. Zlotnik, and T. Suda. 1992. Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J. Immunol. 149:2281-2285.
43. Lecomte, O., J. B. Bock, B. W. Birren, D. Vollrath, and J. R. Parnes. 1996. Molecular linkage of the mouse CD5 and CD6 genes. Immunogenetics 44:385-390.
44. Gimferrer, I., M. Farnós, M. Calvo, M. Mittelbrunn, C. Enrich, F. Sánchez-Madrid, J. Vives, and F. Lozano. 2003. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells. J. Biol. Chem. 278:8564-8571.
45. Singer, N. G., D. A. Fox, T. M. Haqqi, L. Beretta, J. S. Endres, S. Prohaska, J. R. Parnes, J. Bromberg, and R. M. Sramkoski. 2002. CD6: expression during development, apoptosis and selection of human and mouse thymocytes. Int. Immunol. 14:585-597.
46. Teutsch, M., M. Higer, D. Wang, and H. W. Wortis. 1995. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. Int. Immunol. 7:381-392.
47. Berland, R., and H. H. Wortis. 2003. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl. Acad. Sci. USA 100:13459-13464.
48. Winslow, M. M., E. M. Gallo, J. R. Neilson, and G. R. Crabtree. 2006. The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity 24:141-152.
49. Hardy, R. R., and K. Hayakawa. 1991. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. USA 88:11550-11554.
50. Herzenberg, L. A., 2000. B-1 cells: the lineage question revisited. Immunol. Rev. 175:9-22.
51. Montecino-Rodriguez, E., H. Leathers, and K. Dorshkind. 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7:293-301.
52. Huang, C. A., C. Henry, J. Iacomini, T. Imanishi-Kari, and H. H. Wortis. 1996. Adult bone marrow contains precursors for CD5+ B cells. Eur. J. Immunol. 26:2537-2540.
53. Stickler, M., and F. Harding. 2001. Peritoneal B-cell development depends on strain, radiation, and time. Exp. Hematol. 29:221-227.
54. Esplin, B. L., R. S. Welner, Q. Zhang, L. A. Borghesi, and P. W. Kincade. 2009. A differentiation pathway for B1 cells in adult bone marrow. Proc. Natl. Acad. Sci. USA 106:5773-5778.
55. Düber, S., M. Hafner, M. Krey, S. Lienenklaus, B. Roy, E. Hobeika, M. Reth, T. Buch, A. Waisman, K. Kretschmer, and S. Weiss. 2009. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114:4960-4967.
56. Holodick, N. E., K. Repetny, X. Zhong, and T. L. Rothstein. 2009. Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur. J. Immunol. 39:2383-2394.
57. Kantor, A. B., C. E. Merrill, L. A. Herzenberg, and J. L. Hillson. 1997. An unbiased analysis of V (H)-D-J (H) sequences from B-1a, B-1b, and conventional B cells. J. Immunol. 158:1175-1186.
58. Gu, H., I. Förster, and K. Rajewsky. 1990. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J. 9:2133-2140.
59. Kopf, M., F. Brombacher, P. D. Hodgkin, A. J. Ramsay, E. A. Milbourne, W. J. Dai, K. S. Ovington, C. A. Behm, G. Köhler, I. G. Young, and K. I. Matthaei. 1996. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 4:15-24.
60. Yoshida, T., K. Ikuta, H. Sugaya, K. Maki, M. Takagi, H. Kanazawa, S. Sunaga, T. Kinashi, K. Yoshimura, J. Miyazaki, et al. 1996. Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity 4:483-494.
61. Witt, C. M., W. J. Won, V. Hurez, and C. A. Klug. 2003. Notch2 hap-loinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J. Immunol. 171:2783-2788.
62. Thiriot, A., A. M. Drapier, P. Vieira, C. Fitting, J. M. Cavaillon, P. A. Cazenave, and D. Rueff-Juy. 2007. The Bw cells, a novel B cell population conserved in the whole genus Mus. J. Immunol. 179:6568-6578.
63. Haas, K. M., and D. M. Estes. 2000. Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes. Immunology 99:272-278.
64. Weiss, A., M. Iwashima, B. Irving, N. S. van Oers, T. A. Kadlecek, D. Straus, and A. Chan. 1994. Molecular and genetic insights into T cell antigen receptor signal transduction. Adv. Exp. Med. Biol. 365:53-62.
65. Tung, J. W., S. S. Kunnavatana, L. A. Herzenberg, and L. A. Herzenberg. 2001. The regulation of CD5 expression in murine T cells. BMC Mol. Biol. 2:5.
66. Arman, M., J. Calvo, M. E. Trojanowska, P. N. Cockerill, M. Santana, M. López-Cabrera, J. Vives, and F. Lozano. 2004. Transcriptional regulation of human CD5: important role of Ets transcription factors in CD5 expression in T cells. J. Immunol. 172:7519-7529.
67. Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-306.
68. Ordoñez-Rueda, D., F. Lozano, A. Sarukhan, C. Raman, E. A. Garcia-Zepeda, and G. Soldevila. 2009. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling. Eur. J. Immunol. 39:2233-2247.
69. Itoh, M., T. Takahashi, N. Sakaguchi, Y. Kuniyasu, J. Shimizu, F. Otsuka, and S. Sakaguchi. 1999. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317-5326.
70. Suri-Payer, E., A. Z. Amar, A. M. Thornton, and E. M. Shevach. 1998. CD4+ CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-1218.